Overall rank by patents
#32,728
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
OVR holds 8 US patents across 5 technology areas, rank #32,728 of 50,000 tracked assignees.
OVR Tech, Llc has been granted 8 US utility patents between 2020 and 2025, placing OVR Tech, Llc at rank #32,728 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.5 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a US Corporation, OVR Tech, Llc is one of the more focused assignees in the PatentsView dataset. By volume, OVR sits between Osaka Sealing Printing Co., Ltd. (8 patents, rank #32,724) and Ocutec Limited (8 patents, rank #32,732) - the closest US assignees by grant volume. The composite Innovation Score of 47.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. OVR Tech, Llc's 19.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark OVR Tech, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
OSAKA SEALING PRINTING CO., LTD.
8 patents
OSNEXUS CORPORATION
8 patents
OSTRICH PHARMA KK
8 patents
OUR NEW MEDICAL TECHNOLOGIES
8 patents
OXFORD BROOKES UNIVERSITY
8 patents
Oakmoore Pty Ltd
8 patents
Octet Medical, Inc.
8 patents
Ocutec Limited
8 patents
OVR Tech, LLC
8 patents
What this shows OVR holds 8 patents at rank #32,728, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,728 in granted patent volume.
Other assignees with the most granted patents in OVR's primary technology class.
OVR's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 12.5% |
| 2022 | 2 | 25.0% |
| 2023 | 1 | 12.5% |
| 2024 | 3 | 37.5% |
| 2025 | 1 | 12.5% |
Top 5 of 5 technology areas
Overall rank by patents
#32,728
Across all tracked assignees
47.2 out of 100
How to use this portfolio
OVR's 8 grants land it in the top 19% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.